Molecular modelling assisted design and synthesis of cyclothialidine derivatives as DNA gyrase inhibitors

  • Bo Shan

Student thesis: Doctoral ThesisDoctor of Philosophy


Since cyclothialidine was discovered as the most active DNA gyrase inhibitor in 1994, enormous efforts have been devoted to make it into a commercial medicine by a number of pharmaceutical companies and research groups worldwide. However, no serious breakthrough has been made up to now. An essential problem involved with cyclothialidine is that though it demonstrated the potent inhibition of DNA gyrase, it showed little activity against bacteria. This probably is attributable to its inability to penetrate bacterial cell walls and membranes. We applied the TSAR programme to generate a QSAR equation to the gram-negative organisms. In that equation, LogP is profoundly indicated as the key factor influencing the cyclothialidine activity against bacteria. However, the synthesized new analogues have failed to prove that. In the structure based drug design stage, we designed a group of open chain cyclothialidine derivatives by applying the SPROUT programme and completed the syntheses. Improved activity is found in a few analogues and a 3D pharmacophore of the DNA gyrase B is proposed to lead to synthesis of the new derivatives for development of potent antibiotics.
Date of AwardSept 2003
Original languageEnglish
SupervisorCarl H Schwalbe (Supervisor)


  • Molecular modelling
  • assisted design
  • synthesis
  • cyclothialidine derivatives
  • DNA gyrase inhibitors

Cite this